In general, in carcinomas a higher level of TLR2 and a lower PPAR-γ is expressed. There was a trend towards decreased TOLLIP and PPAR-γ from normal mucosa to adenoma/carcinoma. These suggest a possible role of this signaling pathways in development and progression of colon cancers. The gene discussed is TLR2; the disease is adenoma.